Biotech

All Articles

ReNeuron leaving AIM substitution after missing fundraising target

.ReNeuron has joined the long checklist of biotechs to leave London's goal securities market. The st...

MBX apply for IPO to take challenger to Ascendis right into stage 3

.MBX Biosciences has actually included in the current spurt of IPO filings. The biotech, which submi...

FDA increases probing right into Lykos' MDMA trials: WSJ

.For Lykos Rehabs as well as the firm's prospective MDMA-assisted therapy for post-traumatic stress ...

Gene publisher Volume laying off 131 laborers

.Merely times after gene editor Volume Biosciences introduced unrevealed working slices, a clearer p...

Repare gives up 25% of workers as biotech halts preclinical R&ampD

.Repare Therapeutics is actually laying off a fourth of its staff as the oncology biotech lessen its...

J &amp J files for FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually taken an additional measure towards understanding a yield on its ...

Gain's stage 1 win paves way to prove Parkinson's drug's worth

.Increase Therapies has established its direct showing the efficiency of its own Parkinson's ailment...

Actinogen files brand new period 2 records to salvage depression medicine

.Actinogen Medical's hopes-- and supply cost-- have actually rebounded slightly coming from earlier ...

Pfizer and also Front runner incorporate Quotient to multibillion-dollar equation

.Flagship Pioneering and also Pfizer have added Ratio in to their 10-program partnership, inking a p...

Bayer markers $547M contract to drive perimeters of noncoding RNA

.Bayer executives were actually keen to tension to Brutal this summertime that the German pharma tit...